Drug Type Small molecule drug |
Synonyms DW-224AA, 자보란테정 |
Mechanism Bacterial DNA gyrase inhibitors, Topoisomerase IV inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (20 Mar 2015), |
Regulation- |
Molecular FormulaC19H20FN5O4 |
InChIKeyZNPOCLHDJCAZAH-UHFFFAOYSA-N |
CAS Registry219680-11-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Respiratory Tract Infections | KR | 20 Mar 2015 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Phase 1 | - | - |